Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Assessment of a Laboratory-Based SARS-CoV-2 Antibody Test Among Hemodialysis Patients: A Quality Improvement Initiative

Dena E. Cohen, Gilbert Marlowe, Gabriel Contreras, Marie Ann Sosa, Jair Munoz Mendoza, Oliver Lenz, Zain Mithani, Pura Margarita Teixeiro, Nery Queija, Araceli Moneda, Jean S. Jeanty, Katie Swanzy, Misha Palecek, Mahesh Krishnan, Jeffrey Giullian, Steven M. Brunelli
doi: https://doi.org/10.1101/2020.08.03.20163642
Dena E. Cohen
1DaVita Clinical Research, Minneapolis, Minnesota, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilbert Marlowe
1DaVita Clinical Research, Minneapolis, Minnesota, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriel Contreras
2Department of Nephrology, University of Miami, Florida, USA
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie Ann Sosa
2Department of Nephrology, University of Miami, Florida, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jair Munoz Mendoza
2Department of Nephrology, University of Miami, Florida, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Lenz
2Department of Nephrology, University of Miami, Florida, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zain Mithani
2Department of Nephrology, University of Miami, Florida, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pura Margarita Teixeiro
2Department of Nephrology, University of Miami, Florida, USA
APRN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nery Queija
2Department of Nephrology, University of Miami, Florida, USA
APRN, NP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Araceli Moneda
2Department of Nephrology, University of Miami, Florida, USA
NP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean S. Jeanty
2Department of Nephrology, University of Miami, Florida, USA
NP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katie Swanzy
3DaVita Inc, Denver, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Misha Palecek
3DaVita Inc, Denver, Colorado, USA
MBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahesh Krishnan
3DaVita Inc, Denver, Colorado, USA
MD, MPH, MBA, FASN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Giullian
3DaVita Inc, Denver, Colorado, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven M. Brunelli
1DaVita Clinical Research, Minneapolis, Minnesota, USA
MD, MSCE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: steven.brunelli{at}davita.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction The coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Although tests to detect anti-SARS-CoV-2 antibodies have been developed, their sensitivity and specificity in hemodialysis patients have not been previously assessed.

Methods As part of a quality improvement (QI) initiative, nasopharyngeal swabs and predialysis blood samples were collected on the same day from adult patients receiving routine hemodialysis care at clinics managed by a large dialysis organization in the greater Miami, Florida region (23 – 30 Apr 2020). Polymerase chain reaction (PCR) tests for SARS-CoV-2 and chemiluminescence immunoassays for anti-SARS-CoV2 antibodies were performed according to manufacturer-specified protocols.

Results Of 715 participants in the QI initiative, 38 had symptomatology consistent with COVID-19 prior to or during the initiative. Among these, COVID-19 was PCR-confirmed in 14 and ruled out in 20, with the remaining 4 being inconclusive. Among the 34 patients with known COVID-19 status, the sensitivity and specificity of the antibody test were 57.1% and 85.0% when either antibody was considered. The remaining 677 patients had no record of symptoms consistent with COVID-19, nor any known exposure. Of these, 38 patients (5.6%) tested positive for anti-SARS-CoV-2 antibodies.

Conclusions The operational characteristics of the laboratory-based antibody test make it sufficient to rule in, but not rule out, SARS-CoV-2 infection in the appropriate clinical circumstance. A substantial proportion of dialysis patients may have had asymptomatic SARS-CoV-2 infection.

Competing Interest Statement

DEC, GM, and SMB are employees of DaVita Clinical Research. SMBs spouse is an employee of AstraZeneca. KS, MP, MK, and JG are employees of DaVita Inc.

Funding Statement

No external funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All study data were derived from statistically deidentified electronic medical records. Therefore, according to title 45, part 46 of the US Department of Health and Human Services Code of Federal Regulations, this study was deemed exempt from institutional review board (IRB) or ethics committee approval (Quorum IRB, Seattle, WA). We adhered to the Declaration of Helsinki and informed consent was not required.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Underlying study data are proprietary to DaVita, Inc

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 04, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Assessment of a Laboratory-Based SARS-CoV-2 Antibody Test Among Hemodialysis Patients: A Quality Improvement Initiative
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Assessment of a Laboratory-Based SARS-CoV-2 Antibody Test Among Hemodialysis Patients: A Quality Improvement Initiative
Dena E. Cohen, Gilbert Marlowe, Gabriel Contreras, Marie Ann Sosa, Jair Munoz Mendoza, Oliver Lenz, Zain Mithani, Pura Margarita Teixeiro, Nery Queija, Araceli Moneda, Jean S. Jeanty, Katie Swanzy, Misha Palecek, Mahesh Krishnan, Jeffrey Giullian, Steven M. Brunelli
medRxiv 2020.08.03.20163642; doi: https://doi.org/10.1101/2020.08.03.20163642
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Assessment of a Laboratory-Based SARS-CoV-2 Antibody Test Among Hemodialysis Patients: A Quality Improvement Initiative
Dena E. Cohen, Gilbert Marlowe, Gabriel Contreras, Marie Ann Sosa, Jair Munoz Mendoza, Oliver Lenz, Zain Mithani, Pura Margarita Teixeiro, Nery Queija, Araceli Moneda, Jean S. Jeanty, Katie Swanzy, Misha Palecek, Mahesh Krishnan, Jeffrey Giullian, Steven M. Brunelli
medRxiv 2020.08.03.20163642; doi: https://doi.org/10.1101/2020.08.03.20163642

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Nephrology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)